Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...
Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...